Administrative Access: Connect Coverage, Resolution and Cash

Public fact: Fierce Healthcare and Healthcare Dive reported on June 15 that CMS has created a new Office of Health Technology and Products, expanding the agency's role in interoperability initiatives and digital product strategy. The move builds on CMS' broader Health Technology Ecosystem work, which is explicitly focused on patient access, digital tools, and administrative workflow modernization.

CMS’s organizational change gives health technology a clearer institutional home. It does not by itself demonstrate a new procurement budget or that a particular architecture will become universal. I would treat the announcement as context for buyer diligence.

The proposal should identify the specific authorization, access or exchange problem, the institution accountable for it and the resources required to implement the change. This converts policy relevance into a bounded commercial proposition.

Public fact: Fierce Healthcare reported June 15 on new KFF analysis showing insurer participation in the ACA marketplaces declined from 2025 to 2026, with the average number of issuers per state dropping from 9.6 to 9.0 and the number of counties with just one participating insurer increasing from 93 to 165. On the same day, Healthcare Dive reported that a federal judge vacated major pieces of the 2025 ACA enrollment and eligibility rule, including provisions that would have shortened enrollment and added more friction to reenrollment and special enrollment pathways.

National changes in issuer participation can conceal substantial geographic differences. I would map the proposed service against the actual plan choices and provider relationships in the target market, rather than applying an aggregate participation trend uniformly.

Enrollment-rule changes introduce a separate operational dependency. Product and growth plans should accommodate changing verification and timing requirements while preserving clear communication and human assistance. The investment case depends on successful coverage transitions and service access, not clicks or attempted enrollments.

Public fact: Cedar said on June 15 that its Kora AI billing agent has handled nearly 400,000 patient calls since launch, with provider examples including a 24% reduction in live-agent handle time and a 22% reduction in call-center staffing at Gastro Health. Trade coverage framed the result as one of the clearer recent examples of healthcare AI being measured against operational throughput rather than a demo narrative.

The Cedar figures are company-reported operating examples, not an independently established effect for every provider. A reduction in handle time or staffing can arise alongside changes in volume, case mix or service design. Those factors matter when transferring the result to another institution.

I would build a local comparison that includes repeat contacts, unresolved bills, escalation, patient comprehension and total service cost. Staff time becomes a cash benefit only through an actual resource decision. Improved collections should also be reconciled with appropriate financial assistance and accurate explanations of patient responsibility.

Public fact: CMS' proposed rule for the Medicare Drug Price Negotiation Program, announced June 12 and still driving fresh coverage on June 15, would establish a more permanent operating framework for negotiations and clarify how the program handles future eligible products. Coverage on June 15 also highlighted how the proposal could pull newer under-the-skin versions of major infused oncology drugs into the same negotiation logic as their intravenous counterparts.

The proposed negotiation framework raises questions about product classification and future pricing exposure. I would preserve the distinction between a proposal, commentary on its implications and the final rules that ultimately apply.

For an affected service or therapy, the capital plan should examine reimbursement, acquisition cost, administration setting and patient access together. Scenario analysis should show which entity’s margin changes and whether the service remains deliverable under less favorable assumptions.